HUE047813T2 - Lyophilized preparations of melphalan flufenamide - Google Patents
Lyophilized preparations of melphalan flufenamideInfo
- Publication number
- HUE047813T2 HUE047813T2 HUE13849763A HUE13849763A HUE047813T2 HU E047813 T2 HUE047813 T2 HU E047813T2 HU E13849763 A HUE13849763 A HU E13849763A HU E13849763 A HUE13849763 A HU E13849763A HU E047813 T2 HUE047813 T2 HU E047813T2
- Authority
- HU
- Hungary
- Prior art keywords
- lyophilized preparations
- melphalan flufenamide
- flufenamide
- melphalan
- lyophilized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261719184P | 2012-10-26 | 2012-10-26 | |
| SE1251211 | 2012-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE047813T2 true HUE047813T2 (en) | 2020-05-28 |
Family
ID=69399521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13849763A HUE047813T2 (en) | 2012-10-26 | 2013-10-24 | Lyophilized preparations of melphalan flufenamide |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR102226082B1 (en) |
| DK (1) | DK2928463T3 (en) |
| ES (1) | ES2768268T3 (en) |
| HR (1) | HRP20192139T1 (en) |
| HU (1) | HUE047813T2 (en) |
| LT (1) | LT2928463T (en) |
| PT (1) | PT2928463T (en) |
| ZA (1) | ZA201503635B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0002202D0 (en) * | 2000-06-13 | 2000-06-13 | Karolinska Innovations Ab | New peptides |
| CN101584669B (en) * | 2009-06-19 | 2010-12-29 | 江苏奥赛康药业有限公司 | Melphalan freeze-dried powder injection |
| WO2011078782A1 (en) * | 2009-12-22 | 2011-06-30 | Oncopeptides Ab | A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer |
| US20140128462A1 (en) * | 2011-04-28 | 2014-05-08 | Oncopeptides Ab | Lyophilized preparation of cytotoxic dipeptides |
-
2013
- 2013-10-24 LT LTEP13849763.1T patent/LT2928463T/en unknown
- 2013-10-24 PT PT138497631T patent/PT2928463T/en unknown
- 2013-10-24 HU HUE13849763A patent/HUE047813T2/en unknown
- 2013-10-24 KR KR1020207015430A patent/KR102226082B1/en active IP Right Grant
- 2013-10-24 ES ES13849763T patent/ES2768268T3/en active Active
- 2013-10-24 DK DK13849763.1T patent/DK2928463T3/en active
-
2015
- 2015-05-22 ZA ZA2015/03635A patent/ZA201503635B/en unknown
-
2019
- 2019-11-28 HR HRP20192139TT patent/HRP20192139T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2928463T (en) | 2020-02-25 |
| DK2928463T3 (en) | 2020-02-24 |
| HRP20192139T1 (en) | 2020-02-21 |
| LT2928463T (en) | 2020-02-10 |
| KR102226082B1 (en) | 2021-03-10 |
| ZA201503635B (en) | 2021-08-25 |
| ES2768268T3 (en) | 2020-06-22 |
| KR20200081440A (en) | 2020-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216501A1 (en) | Lyophilized preparations of melphalan flufenamide | |
| EP2900264A4 (en) | Glycoprotein preparations | |
| EP2857033A4 (en) | Skin-permeating peptide | |
| HK1215793A1 (en) | Lyophilized formulation of tat-nr2b9c tat-nr2b9c | |
| HK1203161A1 (en) | Peptides and methods of using same | |
| EP2812347A4 (en) | Autophagy-inducing peptide | |
| HK1205524A1 (en) | Engineered conformationally-stabilized proteins | |
| HRP20181782T1 (en) | Pcsk9 peptide vaccine | |
| HK1209138A1 (en) | Peptides | |
| EP3560952C0 (en) | Variant of bpifb4 protein | |
| GB201200555D0 (en) | Peptide | |
| GB201204868D0 (en) | Peptides | |
| GB201223114D0 (en) | Novel peptide | |
| ZA201503635B (en) | Lyophilized preparations of melphalan flufenamide | |
| EP2891663A4 (en) | Psf1-derived peptide | |
| GB201213672D0 (en) | Protein | |
| GB201203101D0 (en) | Preparations of antibacterial bisbenzimidazoles | |
| GB201221414D0 (en) | Trans-locating peptide | |
| GB201200624D0 (en) | Peptide | |
| GB201200623D0 (en) | Peptide | |
| GB201215901D0 (en) | Protein modification | |
| GB201220328D0 (en) | Peptides | |
| GB201214769D0 (en) | Methodsa and peptides | |
| GB201211740D0 (en) | Peptides | |
| GB201207895D0 (en) | Peptides |